PP
LRMR icon

PDT Partners’s Larimar Therapeutics LRMR Stock Holding History

PDT Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,633
Closed -$54K – 438
2019
Q1 		$54K Sell
1,633
-185
-10% -$9.48K ﹤0.01% 424
2018
Q4 		$108K Buy
1,818
+507
+39% +$50K 0.01% 441
2018
Q3 		$184K Sell
1,311
-324
-20% -$39.3K 0.01% 437
2018
Q2 		$201K Sell
1,635
-1,301
-44% -$111K 0.01% 470
2018
Q1 		$262K Buy
2,936
+469
+19% +$39.8K 0.01% 500
2017
Q4 		$137K Sell
2,467
-2,675
-52% -$121K ﹤0.01% 518
2017
Q3 		$217K Sell
5,142
-1,075
-17% -$44.7K 0.01% 489
2017
Q2 		$262K Hold
6,217
– – 0.01% 464
2017
Q1 		$348K Buy
+6,217
New +$309K 0.02% 412

Other funds holding LRMR

AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return